BioNTech founders contributing to book on COVID-19 vaccine
The husband and wife team who helped develop the first COVID-19 vaccine are contributing to a book
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The husband and wife team who helped make the first COVID-19 vaccine are contributing to a book about their efforts. BioNTech founders Ugur Sahin and Özlem Türeci are collaborating with Joe Miller of the Financial Times on “The Vaccine ” St. Martin's Publishing Group announced Tuesday.
Publication is scheduled for Nov. 2. That's one week before a book by the head of Pfizer which teamed up with the Germany-based BioNTech to develop the vaccine, is scheduled to come out.
“'The Vaccine' will reveal how they were able to develop a panel of vaccine candidates within a matter of weeks, how they convinced major pharmaceutical companies to support their work, how they navigated negotiations with the U.S. administration and the European Union, and how in partnership with Pfizer they managed to produce more than two billion doses for countries around the world,” according to St. Martin's.
“Drs. Sahin and Türeci will explain the 30 years of scientific research that laid the foundations for the first Covid-19 vaccine, at a time when public confidence in its safety and efficacy is crucial to offering humanity a route out of this pandemic. And, they will offer a glimpse into the potential treatment of other diseases that the success of the BioNTech vaccine offers.”
Pfizer Chairman and CEO Albert Bourla is also working on a book, announced last month. Harper Business is publishing Bourla's “Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible” on Nov. 9.
Pfizer last December became the first U.S. company to have a vaccine authorized by the FDA, which days later approved a vaccine by Moderna and in February one by Johnson & Johnson.